Skip to main content
SpringerLink
Log in

Clinical, Endoscopic, and Pathological Characteristics of Immune Checkpoint Inhibitor-Induced Gastroenterocolitis

  • Case Report
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Hodi FS, Mihm MC, Soiffer RJ, et al. Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients. Proc Natl Acad Sci U S A. 2003;100:4712–4717.

    Article  CAS  Google Scholar 

  2. Topalian SL, Hodi FS, Brahmer JR, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med. 2012;366:2443–2454.

    Article  CAS  Google Scholar 

  3. Ribas A, Hamid O, Daud A, et al. Association of pembrolizumab with tumor response and survival among patients with advanced melanoma. JAMA. 2016;315:1600–1609.

    Article  CAS  Google Scholar 

  4. Gupta A, De Felice KM, Loftus EV Jr, Khanna S. Systematic review: colitis associated with anti-CTLA-4 therapy. Aliment Pharmacol Ther. 2015;42:406–417.

    Article  CAS  Google Scholar 

  5. Haanen J, Carbonnel F, Robert C, et al. Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29:iv264-iv6.

    Article  Google Scholar 

  6. Haanen J, Carbonnel F, Robert C, et al. Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28:iv119-iv42.

    Article  Google Scholar 

  7. Wang Y, Abu-Sbeih H, Mao E, et al. Immune-checkpoint inhibitor-induced diarrhea and colitis in patients with advanced malignancies: retrospective review at MD Anderson. J Immunother Cancer. 2018;6:37.

    Article  Google Scholar 

  8. Beck KE, Blansfield JA, Tran KQ, et al. Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4. J Clin Oncol. 2006;24:2283–2289.

    Article  CAS  Google Scholar 

  9. Marthey L, Mateus C, Mussini C, et al. Cancer immunotherapy with anti-CTLA-4 monoclonal antibodies induces an inflammatory bowel disease. J Crohns Colitis. 2016;10:395–401.

    Article  CAS  Google Scholar 

  10. Collins M, Michot JM, Danlos FX, et al. Inflammatory gastrointestinal diseases associated with PD-1 blockade antibodies. Ann Oncol. 2017;28:2860–2865.

    Article  CAS  Google Scholar 

  11. Yanai S, Nakamura S, Kawasaki K, et al. Immune checkpoint inhibitor-induced diarrhea: clinicopathological study of 11 patients. Dig Endosc. 2020;32:616–620.

    Article  Google Scholar 

Download references

Acknowledgment

We thank Dr. Jason Cohen for the English language review.

Author information

Authors and Affiliations

  1. Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan

    Yukie Hayashi, Kenji J. L. Limpias Kamiya, Kai Tsugaru, Keitaro Shimozaki, Tomohisa Sujino, Yasutaka Sukawa, Yasuo Hamamoto, Makoto Naganuma & Takanori Kanai

  2. Center for Diagnostic and Therapeutic Endoscopy, Keio University School of Medicine, 35 Shinanomachi, Shinjuku, Tokyo, 160-8582, Japan

    Naoki Hosoe, Kaoru Takabayashi, Seiichiro Fukuhara, Makoto Mutaguchi & Haruhiko Ogata

  3. Keio Cancer Center, Keio University School of Medicine, Tokyo, Japan

    Kenro Hirata

  4. Center for Preventive Medicine, Keio University School of Medicine, Tokyo, Japan

    Kayoko Fukuhara & Hiromasa Takaishi

  5. Department of Pathology, Keio University School of Medicine, Tokyo, Japan

    Masayuki Shimoda

Authors
  1. Yukie Hayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Naoki Hosoe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kaoru Takabayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kenji J. L. Limpias Kamiya
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kai Tsugaru
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Keitaro Shimozaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kenro Hirata
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Kayoko Fukuhara
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Seiichiro Fukuhara
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Makoto Mutaguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Tomohisa Sujino
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Yasutaka Sukawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Yasuo Hamamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Makoto Naganuma
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Hiromasa Takaishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Masayuki Shimoda
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Haruhiko Ogata
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Takanori Kanai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Naoki Hosoe.

Ethics declarations

Conflict of interest

There are no conflicts of interest to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 791 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hayashi, Y., Hosoe, N., Takabayashi, K. et al. Clinical, Endoscopic, and Pathological Characteristics of Immune Checkpoint Inhibitor-Induced Gastroenterocolitis. Dig Dis Sci 66, 2129–2134 (2021). https://doi.org/10.1007/s10620-020-06441-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-020-06441-w

Keywords

Search

Navigation